| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 156, Issue 3 916-921, Copyright © 1996 by American Association of Immunologists
ARTICLES |
Y Ke and JA Kapp
Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322, USA.
We have been investigating the mechanisms by which exogenous protein Ags activate CD8+ T cells. Previously, we have shown that OVA primed CTL precursors in vivo if administered as an emulsion with an adjuvant such as CFA. Such CTLs inhibit development of Ab responses when adoptively transferred into syngeneic mice. Thus, CD8+ CTL are immunosuppressive. These studies were initiated to determine whether CD8+ suppressor T cells were cytolytic T cells. Oral administration of protein Ags is a well-established method for inducing tolerance in humoral and delayed hypersensitivity responses which is associated with development of CD8+ suppressor T cells. OVA was chosen as a model Ag because it has been used extensively in oral tolerance studies, and target cells expressing the OVA gene are well characterized. Our data show that multiple, intragastric doses of native OVA inhibited priming of CD8+ CTL precursors and also inhibited CD4+ T cells and Ab responses. Oral OVA inhibited CTL priming in mice immunized with OVA- loaded EL4 cells, OVA-expressing transfectants, or OVA in CFA. The observed tolerance is specific to the orally administered Ag. Although oral OVA did not prime CTL precursors, it did activate spleen cells that transferred unresponsiveness to naive syngeneic mice. Suppression was mediated by CD4-CD8+ T cells. These CD8+ suppressor T cells were phenotypically distinguished from CTL by reactivity with a mAb that recognizes activated suppressor T cells.
This article has been cited by other articles:
|
|
 |
|
  H. M. Ashour and J. Y. Niederkorn {gamma}{delta} T Cells Promote Anterior Chamber-Associated Immune Deviation and Immune Privilege through Their Production of IL-10 J. Immunol., December 15, 2006; 177(12): 8331 - 8337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Xia, S. Hao, and J. Xiang CD8+ Cytotoxic T-APC Stimulate Central Memory CD8+ T Cell Responses via Acquired Peptide-MHC Class I Complexes and CD80 Costimulation, and IL-2 Secretion. J. Immunol., September 1, 2006; 177(5): 2976 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chung, J.-H. Chang, M.-N. Kweon, P. D. Rennert, and C.-Y. Kang CD8{alpha}-11b+ dendritic cells but not CD8{alpha}+ dendritic cells mediate cross-tolerance toward intestinal antigens Blood, July 1, 2005; 106(1): 201 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Li, P. Hu, L. A. Khawli, and A. L. Epstein Complete Regression of Experimental Solid Tumors by Combination LEC/chTNT-3 Immunotherapy and CD25+ T-Cell Depletion Cancer Res., December 1, 2003; 63(23): 8384 - 8392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Zimring, S. B. Levery, B. Kniep, L. M. Kapp, M. Fuller, and J. A. Kapp CD75s is a marker of murine CD8+ suppressor T cells Int. Immunol., November 1, 2003; 15(11): 1389 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-C. Field, L. Caccavelli, M.-F. Bloch, and B. Bellon Regulatory CD8+ T Cells Control Neonatal Tolerance to a Th2-Mediated Autoimmunity J. Immunol., March 1, 2003; 170(5): 2508 - 2515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu and J. A. Kapp {gamma}{delta} T Cells in Anterior Chamber-Induced Tolerance in CD8+ CTL Responses Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3473 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Smith, F. McAskill, and P. Garside Orally Tolerized T Cells Are Only Able to Enter B Cell Follicles Following Challenge with Antigen in Adjuvant, but They Remain Unable to Provide B Cell Help J. Immunol., May 1, 2002; 168(9): 4318 - 4325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, R. I. Carr, R. S. Liwski, A. W. Stadnyk, and T. D. G. Lee Oral Exposure to Alloantigen Generates Intragraft CD8+ Regulatory Cells J. Immunol., July 1, 2001; 167(1): 107 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Desvignes, N. Etchart, J. Kehren, I. Akiba, J.-F. Nicolas, and D. Kaiserlian Oral Administration of Hapten Inhibits In Vivo Induction of Specific Cytotoxic CD8+ T Cells Mediating Tissue Inflammation: A Role for Regulatory CD4+ T Cells J. Immunol., March 1, 2000; 164(5): 2515 - 2522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Biagi, K.P. Zimmer, P.D. Thomas, H.J. Ellis, and P.J. Ciclitira Is gliadin mispresented to the immune system in coeliac disease? A hypothesis QJM, February 1, 1999; 92(2): 119 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P GARSIDE, A M. MOWAT, and A KHORUTS Oral tolerance in disease Gut, January 1, 1999; 44(1): 137 - 142. [Full Text] [PDF]
|
|
|
|
|
|
M. Blank, J. George, V. Barak, A. Tincani, T. Koike, and Y. Shoenfeld Oral Tolerance to Low Dose {beta}2-Glycoprotein I: Immunomodulation of Experimental Antiphospholipid Syndrome J. Immunol., November 15, 1998; 161(10): 5303 - 5312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rueff-Juy, M. Faure, A.-M. Drapier, and P.-A. Cazenave Role of Maternal Ig in the Induction of C{kappa}-Specific CD8+ T Cell Tolerance J. Immunol., July 15, 1998; 161(2): 721 - 728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Grdic, E. Hornquist, M. Kjerrulf, and N. Y. Lycke Lack of Local Suppression in Orally Tolerant CD8-Deficient Mice Reveals a Critical Regulatory Role of CD8+ T Cells in the Normal Gut Mucosa J. Immunol., January 15, 1998; 160(2): 754 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Blanas, F. R. Carbone, J. Allison, J. F. A. P. Miller, and W. R. Heath Induction of Autoimmune Diabetes by Oral Administration of Autoantigen Science, December 6, 1996; 274(5293): 1707 - 11709. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
